Codexis: Pay

Codexis paid its 5 named executives $8.3M in total in FY2025 (Dec). CEO Alison Moore, Ph.D. was paid $2.3M of that.

Pay$100 in the stock at the end of FY23 → $53
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Alison Moore, Ph.D.President and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Stephen Dilly, M.B.B.S, Ph.D.Executive Chair of the Board of Directors and former President and Chief Executive Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)Not disclosed
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Georgia ErbezChief Financial Officer and Chief Business Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Kevin Norrett, M.B.A.Former Chief Operating Officer
FY2025 (Dec)Not disclosed
FY2024 (Dec)Not disclosed
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Stefan Lutz, Ph.D.Chief Scientific Officer
FY2025 (Dec)
1 year

CEO pay against the pay peers

In FY2024 (Dec), the median CEO pay of the 5 peers with pay on file was $4.4M. The CEO of Codexis was paid $3.5M, 22% below the median.

  1. 1Quanterix
  2. 2Regenxbio
  3. 3Quantum-Si
  4. 4Seer
  5. 5Codexis
  6. 6Personalis
  7. 7AbsciNot disclosed
  8. 8Akoya BiosciencesNot disclosed
  9. 9Alpha TeknovaNot disclosed
  10. 10Anika TherapeuticsNot disclosed
  11. 11Avid BioservicesNot disclosed
  12. 12Bionano GenomicsNot disclosed
  13. 13Harvard BiosciencesNot disclosed
  14. 14MaxcyteNot disclosed
  15. 15NanoString TechnologiesNot disclosed
  16. 16Rapid Micro BiosystemsNot disclosed
  17. 17Sangamo TherapeuticsNot disclosed
  18. 18SomaLogicNot disclosed
  19. 19Standards BioToolsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.